{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Diagnostic assay",
      "NeuMoDx",
      "RT-PCR",
      "Rapid testing",
      "SARS-CoV-2"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35217170",
  "DateCompleted": {
    "Year": "2022",
    "Month": "04",
    "Day": "28"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "07",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "02",
        "Day": "23"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.ijid.2022.02.032",
      "S1201-9712(22)00109-6"
    ],
    "Journal": {
      "ISSN": "1878-3511",
      "JournalIssue": {
        "Volume": "118",
        "PubDate": {
          "Year": "2022",
          "Month": "May"
        }
      },
      "Title": "International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",
      "ISOAbbreviation": "Int J Infect Dis"
    },
    "ArticleTitle": "Comparison of the clinical sensitivity and specificity of two commercial RNA SARS-CoV-2 assays.",
    "Pagination": {
      "StartPage": "194",
      "EndPage": "196",
      "MedlinePgn": "194-196"
    },
    "Abstract": {
      "AbstractText": [
        "This study aimed to compare the performance of the NeuMoDx\u2122 SARS-CoV-2 Assay, implemented on the NeuMoDx 96 Molecular System, with that of the ThermoFisher TaqPath\u2122 COVID-19 CE-IVD RT-PCR Kit (reference method).",
        "Overall, 450 nasopharyngeal swab samples, previously tested using the reference method, were tested by the NeuMoDx Assay, and the clinical sensitivity and specificity of the assay were analyzed.",
        "By retrospective statistical analysis of all valid results, the NeuMoDx Assay had a clinical specificity of 100% (95% confidence interval [CI]: 98.65-100.00) and a clinical sensitivity of 98.73% (95% CI: 95.47-99.85).",
        "The NeuMoDx SARS-CoV-2 Assay demonstrated comparable analytical and clinical performance to the ThermoFisher TaqPath COVID-19 CE-IVD RT-PCR Kit. The NeuMoDx 96 Molecular System is well suited for automating medium-throughput routine SARS-CoV-2 testing or as an addition to high-throughput systems to allow fast-tracking for highly urgent clinical samples."
      ],
      "CopyrightInformation": "Copyright \u00a9 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Fleet Street Clinic, 29 Fleet Street, London, EC4Y 1AA, United Kingdom."
          }
        ],
        "LastName": "Litchfield",
        "ForeName": "Mark",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Royal Brompton and Harefield Hospital, 250 King's Road, London, SW3 5UE, United Kingdom."
          }
        ],
        "LastName": "Brookes",
        "ForeName": "Paul",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Royal Brompton and Harefield Hospital, 250 King's Road, London, SW3 5UE, United Kingdom."
          }
        ],
        "LastName": "Ojrzynska",
        "ForeName": "Agnieszka",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Fleet Street Clinic, 29 Fleet Street, London, EC4Y 1AA, United Kingdom."
          }
        ],
        "LastName": "Kavi",
        "ForeName": "Janki",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Fleet Street Clinic, 29 Fleet Street, London, EC4Y 1AA, United Kingdom. Electronic address: richard@aradco.com."
          }
        ],
        "LastName": "Dawood",
        "ForeName": "Richard",
        "Initials": "R"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Canada",
    "MedlineTA": "Int J Infect Dis",
    "NlmUniqueID": "9610933",
    "ISSNLinking": "1201-9712"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "63231-63-0",
      "NameOfSubstance": "RNA"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Testing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "RNA"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Retrospective Studies"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "Declaration of Competing Interest The authors report no competing interests."
}